Concepts (153)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Anne Higgins's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Anne Higgins has written about over time.
Congenital AbnormalitiesCentromereChromosomes, HumanHybrid CellsChromosomes, Human, Pair 3Chromosome AberrationsGenome, HumanHuman DevelopmentChromosome BreakageAbnormalities, MultipleLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMutationAntibodies, BispecificDNA-Binding ProteinsLeukemia, Myeloid, AcuteMyelodysplastic SyndromesDioxygenasesGTP PhosphohydrolasesProto-Oncogene Proteins p21(ras)
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Congenital Abnormalities | 2 | 2003 | 2008 | September 2005 |
| Centromere | 1 | 2005 | 2005 | December 2005 |
| Chromosomes, Human | 1 | 2005 | 2005 | December 2005 |
| Hybrid Cells | 1 | 2005 | 2005 | December 2005 |
| Chromosomes, Human, Pair 3 | 2 | 2007 | 2007 | June 2007 |
| Chromosome Aberrations | 4 | 2003 | 2013 | February 2008 |
| Genome, Human | 1 | 2008 | 2008 | February 2008 |
| Human Development | 1 | 2008 | 2008 | February 2008 |
| Chromosome Breakage | 4 | 2007 | 2011 | August 2008 |
| Abnormalities, Multiple | 3 | 2007 | 2013 | August 2009 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2012 | 2021 | January 2017 |
| Mutation | 7 | 2003 | 2026 | March 2017 |
| Antibodies, Bispecific | 1 | 2021 | 2021 | July 2021 |
| DNA-Binding Proteins | 3 | 2015 | 2026 | November 2021 |
| Leukemia, Myeloid, Acute | 2 | 2021 | 2026 | November 2023 |
| Myelodysplastic Syndromes | 2 | 2021 | 2026 | January 2024 |
| Dioxygenases | 2 | 2024 | 2026 | April 2025 |
| GTP Phosphohydrolases | 1 | 2026 | 2026 | February 2026 |
| Proto-Oncogene Proteins p21(ras) | 1 | 2026 | 2026 | February 2026 |
To return to the timeline,
click here.